CTOs on the Move

Fortress PropTech

www.fortresstech.io

 
Fortress is an all-inclusive property management software. Our platform supports managers and owners with an easy-to-use and informative dashboard, in-system training for employee on-boarding, data storage and real-time automated reporting. We understand the unique challenges property managers face because Fortress was built by operators and property management professionals. Your business depends on secure relationships between residents, managers and owners, and we`re here to help support that growth, meeting you where you are to access the features your property relies on most.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Trada

Trada is a Boulder, CO-based company in the Software and Internet sector.

Imagemachine

Imagemachine is a New York, NY-based company in the Software and Internet sector.

Stitch Labs

Stitch is an online inventory control solution that simplifies multichannel retail business. It automatically syncs inventory, orders, and sales across channels, providing retailers with operational efficiencies and a holistic understanding of their businesses. With Stitch, retailers are able to save time, make better decisions, and grow. We`re relentless about improving the landscape for small retailers. We`re dedicated to providing our customers with the most advanced solutions, so they`re able to grow their businesses and live happier lives.

Fingercheck

Fingercheck is the modern workforce solution that transforms the way small businesses work - making them run smarter. Our All-in-One HR platform, lets businesses easily manage Payroll, Time & Attendance, HR and much more through our easy-to-use, automated software, Fingercheck delivers the tools to simplify and streamline workflow for employees & employers using a single platform so everyone can work more efficiently.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.